Ind-Swift Laboratories' Derabassi Facility Gets GMP Certification from Hungary

MT Newswires Live12-16

Ind-Swift Laboratories (NSE:INDSWFTLAB, BOM:532305) said its formulations facility in Derabassi, Punjab, has been granted a Good Manufacturing Practice (GMP) certificate by Hungary's National Center for Public Health and Pharmacy, according to an Indian bourse filing on Monday.

The certification follows an EUDRA GMP inspection conducted in November, the filing said. It is valid for three years and allows the company to access European and other regulated markets.

The facility already holds WHO-GMP, TGA (Australia), MHRA (UK), SAPRA (South Africa), and EU-GMP certifications, according to the filing.

Ind-Swift Laboratories' shares were down over 1% in Tuesday's trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment